| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $54.8M | +14.6% |
| SG&A Expense | $20.8M | -0.1% |
| Operating Income | -$75.6M | -10.1% |
| Interest Expense | $3.3M | +1172.1% |
| Income Tax | $0 | — |
| Net Income | -$71.2M | -6.1% |
| EPS (Basic) | -$1.37 | +23.0% |
| EPS (Diluted) | -$1.37 | +23.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.6M | +5.1% |
| Short-term Investments | $154.0M | +62.2% |
| Current Assets | $196.3M | +49.4% |
| Total Assets | $200.8M | +44.3% |
| Current Liabilities | $14.7M | -0.2% |
| Long-term Debt | $44.8M | +981.6% |
| Total Liabilities | $60.4M | +190.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.7M | -22.4% |
| Capital Expenditures | $298K | -27.3% |
| Investing Cash Flow | -$53.6M | -892.9% |
| Financing Cash Flow | $126.0M | +73.1% |
| Free Cash Flow | -$71.0M | -22.0% |
| Stockholders' Equity |
| $140.5M |
| +18.7% |